Featured Program
Featured Resources
Featured Advocacy Letters
NCL Sends Letter to Senate HELP Committee on Lowering Healthcare Costs
/in Featured Home - Health/by allisoncAugust 1, 2025: Washington, DC – On July 31, 2025, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the rising cost of healthcare and the urgent need for patient-focused reform. Lawmakers and expert witnesses discussed challenges with employer-sponsored insurance, the lack of price transparency, and the profit-driven nature of the U.S. healthcare system.
Featured Press Releases
NCL, 55 Organizations Urge Lawmakers to Pass the Safety Is Not For Sale Act
/in Featured Home - Traffic Safety/by allisoncMarch 12, 2026: Washington, DC – The National Consumers League (NCL) and 55 of the nation’s most prominent automobile safety and consumer protection organizations sent a letter to leaders of the House Energy and Commerce Committee in support of the Safety is Not For Sale Act. The legislation requires that optional automobile safety systems be made available as part of the base trim or be disclosed and offered for sale separately from non-safety-related equipment.
Fuel Economy Features Save Car Owners Over $9,000 a Year Says National Consumers League
/in Featured Home - Consumer Protection/by Lisa McDonaldMarch 10, 2026: Washington, DC – The National Consumers League (NCL) today sent a letter to the Senate Environment & Public Works Committee in advance of the hearing on S. 3135, the Cold Weather Diesel Reliability Act. The legislation would grant the Environmental Protection Agency the authority to permit vehicle manufacturers to suspend engine shutdown features on diesel vehicles in extreme cold.
National Consumers League Applauds Progress on Responsible GLP-1 Marketing
/in Featured Home - Food, Nutrition, & Obesity/by Lisa McDonaldMarch 9, 2026: Washington, DC – As an organization focused on the safety of GLP-1 weight-loss drugs, the National Consumers League welcomes the agreement between Novo Nordisk and the telehealth platform Hims & Hers as an important step that could turn the tide away from consumers opting for unapproved GLP-1 weight-loss products.
National Consumers League Commends FDA for Swift Action Against Hims & Hers
/in Featured Home - Food, Nutrition, & Obesity/by Lisa McDonaldFebruary 9, 2026: Washington, DC – You can fool some of the people some of the time and all of the people some of the time. But you can’t fool all of the people all the time. On Friday, February 6, the Food and Drug Administration announced it would stop the telehealth platform Hims & Hers from marketing a compounded version of the first FDA-approved GLP-1 weight-loss pill. On Saturday, Hims & Hers said it was withdrawing the product from the market, and the FDA did not pursue enforcement action.